Miguel Romero obtained a bachelor's degree in Pharmacy in 2004 and a doctorate of Pharmacy in 2009 from the University of Granada. Since 2022, he has held the position of Senior Lecturer in the Department of Pharmacology at the University of Granada. He is part of the research group CTS-164 of the Andalusian Government since 2005, within which he has participated in twelve national and regional research projects, in six of which he was the principal investigator. Since 2006, he has collaborated in research contracts with the pharmaceutical and food industries, participating in five of these contracts as collaborator and researcher. Romero's research has focused the study of dietary polyphenols in hypertension and diabetes. Currently, he analyzes the effect of probiotics and drug receptor agonists peroxisome proliferator activated (PPAR) beta in hypertension and systemic lupus erythematosus. He has published over seventy-five scientific articles, collected JCR (70% in the first quartile) and presented more than one hundred papers in national and international conferences. He has spent periods in research centers at King’s College London, Complutense University of Madrid and Université Catholique de Louvain (UCL) in Brussels. Romero has completed three five-year teaching periods and three six-year research periods. Additionally, he has successfully supervised four doctoral theses.